LianBio Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Net Income	-110.29	-196.3	-139.6	-58.39
Depreciation & Amortization	1.01	0.53	0.08	-
Loss (Gain) From Sale of Investments	-1.61	-0.02	-	-
Stock-Based Compensation	19.15	8.66	5.18	-
Other Operating Activities	-15.44	9.4	36.04	22.84
Change in Accounts Receivable	-1.4	14.22	-20	-
Change in Accounts Payable	-1.71	-1.71	4.16	-
Change in Other Net Operating Assets	11.1	1.28	16.01	7.48
Operating Cash Flow	-99.19	-163.95	-98.14	-28.08
Capital Expenditures	-1.85	-0.95	-0.89	-
Investment in Securities	-67.36	-154.99	-	-
Investing Cash Flow	-69.2	-155.94	-0.89	-
Long-Term Debt Issued	-	-	15	-
Net Debt Issued (Repaid)	-	-	15	-
Issuance of Common Stock	1.71	316.63	-	-
Other Financing Activities	-	-6.36	-15.25	-
Financing Cash Flow	1.71	313.27	309.75	132
Foreign Exchange Rate Adjustments	-2.21	0.45	0.33	-
Net Cash Flow	-168.89	-6.17	211.05	103.92
Free Cash Flow	-101.03	-164.9	-99.03	-28.08
Free Cash Flow Per Share	-0.94	-4.79	-8.22	-5.76
Cash Income Tax Paid	0.38	-	-	-
Levered Free Cash Flow	-46.25	-99.71	-102.78	-
Unlevered Free Cash Flow	-46.25	-99.71	-99.75	-
Change in Net Working Capital	-13.79	-14.28	19.83	-

Updated Nov 13, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.